DRTS Stock Price, Chart, Stats & News

Alpha Tau Medical Ltd
Save
885.19M
Market cap
–
Current P/E
–
Forward P/E
DRTS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.32% |
ROA | -40.00% |
ROE | -57.29% |
D/E | 0.18x |
Interest coverage ratio | – |
DRTS valuation
P/E | – |
P/S | – |
P/B | 7.62x |
P/CF | -22.03x |
P/FCF | -18.43x |
P/OCF | -22.03x |
PEG | -0.14x |
EV multiple | -14.59x |
About
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
Similar securities
Based on sector and market capitalization
Report issue











